Navigation Links
AutoGenomics Announces the Launch of a Novel Test for B-RAF Mutations

CARLSBAD, Calif., Feb. 24 /PRNewswire/ -- AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.

The featured four-part series in The New York Times, this week focuses on the importance of B-RAF mutations and the next generation of cancer therapies. "We congratulate Plexxikon and Roche on the dramatic success of their compound PLX-4032, a novel treatment for melanoma and other cancers harboring the V600E mutation of the B-RAF kinase gene," said Robert Cole, M.D., Chief Medical Officer at AutoGenomics.

Melanoma is the most serious type of skin cancer with about 70,000 new melanoma cases diagnosed every year in the USA and about 160,000 worldwide. When diagnosed early melanoma is curable, however advanced stage disease has carried a poor prognosis up to now.

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the era of personalized medicine.

SOURCE AutoGenomics

Back to top



SOURCE AutoGenomics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AutoGenomics Receives ISO Certification
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. FDA Announces Possible Safety Concern for HIV Drug Combination
5. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
6. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
7. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
8. Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
9. Pioneer(R) Surgical Technology, Inc. Announces New CTO
10. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
11. Echo Therapeutics Announces Significant Product Development Milestone: The Completion of Next Generation Electronic Components for Its Revolutionary, Patented Symphony(TM) tCGM System
Post Your Comments:
(Date:11/24/2015)... COMMACK , Nueva York ... Avery Biomedical Devices (ABD), fabricante del Avery Breathing ... Anders Jonzon , MD; Ph.D. como consultor ...   --> Foto - ... --> El doctor Jonzon es un ...
(Date:11/24/2015)... 24, 2015 Avery Biomedical Devices (ABD), manufacturer ... announce the appointment of Anders Jonzon , MD; ... Dr. Jonzon is a Physiologist ... Hospital, Uppsala University, Uppsala and Children,s Hospital, Karolinska, ... a fellow at the Cardiovascular Institute (UCSF). His research ...
(Date:11/24/2015)... F1000Workspace - a research collaboration, reference management ... just six months ago. --> F1000Workspace - ... - since it was launched just six months ago. ... F1000Workspace - a research collaboration, reference management and ... six months ago. --> --> ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... The hospitals and health ... aspects of orthopedic care. They have received recognition for excellence from various reputable ... , Becker's Hospital Review selected hospitals for inclusion based on national rankings ...
(Date:11/24/2015)... ... November 24, 2015 , ... In response to recent news highlighting ... from prescription opioids in the United States grew 400 percent between 1999 and 2010, ... were involved in 37 percent of all fatal drug overdoses. (1) , While oxycodone ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Serenity Point ... a series of recent video interviews with some of the staff members at their ... the residential treatment facility, as well as some of the things that make their ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson ... (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College ... III on October 16. , “Katie is very excited and greatly appreciative to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading ... driven by social media and the generosity of people around the world. On December ... media networks to give – and share the personal stories behind those gifts. ...
Breaking Medicine News(10 mins):